A detailed history of Nomura Asset Management CO LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Nomura Asset Management CO LTD holds 343,586 shares of LLY stock, worth $264 Million. This represents 0.96% of its overall portfolio holdings.

Number of Shares
343,586
Previous 332,313 3.39%
Holding current value
$264 Million
Previous $301 Million 1.17%
% of portfolio
0.96%
Previous 1.04%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$772.14 - $960.02 $8.7 Million - $10.8 Million
11,273 Added 3.39%
343,586 $304 Million
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $40.3 Million - $50.5 Million
-55,536 Reduced 14.32%
332,313 $301 Million
Q1 2024

May 13, 2024

BUY
$592.2 - $792.28 $4.54 Million - $6.07 Million
7,666 Added 2.02%
387,849 $302 Million
Q4 2023

Feb 09, 2024

BUY
$525.19 - $619.13 $11.4 Million - $13.5 Million
21,755 Added 6.07%
380,183 $222 Million
Q3 2023

Nov 03, 2023

SELL
$434.7 - $599.3 $19.2 Million - $26.5 Million
-44,138 Reduced 10.96%
358,428 $193 Million
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $5.6 Million - $7.49 Million
15,966 Added 4.13%
402,566 $189 Million
Q1 2023

May 11, 2023

BUY
$310.63 - $364.82 $15.7 Million - $18.4 Million
50,439 Added 15.0%
386,600 $133 Million
Q4 2022

Feb 14, 2023

BUY
$321.55 - $374.67 $13.2 Million - $15.3 Million
40,902 Added 13.85%
336,161 $123 Million
Q3 2022

Nov 10, 2022

SELL
$296.48 - $337.87 $12.4 Million - $14.1 Million
-41,804 Reduced 12.4%
295,259 $95.5 Million
Q2 2022

Aug 12, 2022

BUY
$278.73 - $327.27 $7.29 Million - $8.56 Million
26,149 Added 8.41%
337,063 $109 Million
Q1 2022

May 13, 2022

SELL
$234.69 - $291.66 $14.9 Million - $18.5 Million
-63,519 Reduced 16.96%
310,914 $89 Million
Q4 2021

Feb 01, 2022

BUY
$224.85 - $279.04 $22.3 Million - $27.7 Million
99,393 Added 36.14%
374,433 $103 Million
Q3 2021

Nov 12, 2021

BUY
$221.6 - $272.71 $333,508 - $410,428
1,505 Added 0.55%
275,040 $63.5 Million
Q2 2021

Aug 06, 2021

BUY
$180.55 - $233.54 $2.13 Million - $2.75 Million
11,791 Added 4.5%
273,535 $62.8 Million
Q1 2021

May 14, 2021

SELL
$164.32 - $212.72 $815,684 - $1.06 Million
-4,964 Reduced 1.86%
261,744 $48.9 Million
Q4 2020

Feb 12, 2021

BUY
$130.46 - $172.63 $1.86 Million - $2.46 Million
14,251 Added 5.64%
266,708 $45 Million
Q3 2020

Nov 12, 2020

BUY
$146.22 - $169.13 $9.29 Million - $10.7 Million
63,503 Added 33.61%
252,457 $37.4 Million
Q2 2020

Aug 13, 2020

SELL
$136.42 - $164.18 $1.55 Million - $1.86 Million
-11,344 Reduced 5.66%
188,954 $31 Million
Q1 2020

May 14, 2020

BUY
$119.05 - $147.35 $588,464 - $728,351
4,943 Added 2.53%
200,298 $27.8 Million
Q4 2019

Feb 13, 2020

SELL
$106.92 - $132.43 $2.3 Million - $2.85 Million
-21,526 Reduced 9.93%
195,355 $25.7 Million
Q3 2019

Nov 13, 2019

BUY
$106.79 - $116.16 $2 Million - $2.18 Million
18,773 Added 9.48%
216,881 $24.3 Million
Q2 2019

Aug 13, 2019

SELL
$110.79 - $129.32 $424,214 - $495,166
-3,829 Reduced 1.9%
198,108 $21.9 Million
Q1 2019

May 10, 2019

SELL
$111.31 - $131.02 $33.9 Million - $39.9 Million
-304,807 Reduced 60.15%
201,937 $26.2 Million
Q4 2018

Feb 12, 2019

BUY
$105.9 - $118.64 $2.35 Million - $2.63 Million
22,169 Added 4.57%
506,744 $58.6 Million
Q3 2018

Nov 07, 2018

SELL
$85.86 - $107.31 $22.3 Million - $27.9 Million
-259,951 Reduced 34.91%
484,575 $52 Million
Q2 2018

Aug 03, 2018

SELL
$75.7 - $86.88 $1.92 Million - $2.2 Million
-25,300 Reduced 3.29%
744,526 $63.5 Million
Q1 2018

May 14, 2018

BUY
$74.21 - $87.6 $724,734 - $855,501
9,766 Added 1.28%
769,826 $59.6 Million
Q4 2017

Feb 14, 2018

BUY
$81.94 - $87.89 $12.2 Million - $13.1 Million
148,955 Added 24.37%
760,060 $64.2 Million
Q3 2017

Nov 13, 2017

BUY
$77.07 - $85.54 $4.47 Million - $4.96 Million
58,011 Added 10.49%
611,105 $52.3 Million
Q2 2017

Aug 14, 2017

BUY
N/A
553,094
553,094 $45.5 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Nomura Asset Management CO LTD Portfolio

Follow Nomura Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.